Form 8-K - Current report:
SEC Accession No. 0001663577-21-000656
Filing Date
2021-12-10
Accepted
2021-12-10 13:11:01
Documents
12
Period of Report
2021-12-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 abti8k.htm   iXBRL 8-K 19525
  Complete submission text file 0001663577-21-000656.txt   183459

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abti-20211208.xsd EX-101.SCH 3046
3 XBRL LABEL FILE abti-20211208_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE abti-20211208_pre.xml EX-101.PRE 22373
5 EXTRACTED XBRL INSTANCE DOCUMENT abti8k_htm.xml XML 3167
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 333-156091 | Film No.: 211484579
SIC: 2833 Medicinal Chemicals & Botanical Products